CCM
TMCI icon

CAAS Capital Management’s Treace Medical Concepts TMCI Stock Holding History

CAAS Capital Management’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-150,000
Closed -$4.69M – 1113
2021
Q2 		$4.69M Buy
+150,000
New +$4.77M 0.08% 250

Other funds holding TMCI

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
NCGI
Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

CAAS Capital Management's TMCI Position: Q3 2021 in Review

CAAS Capital Management sold out of Treace Medical Concepts (TMCI) in Q3 2021, closing a stake of 150,000 shares — an estimated $4.69M sold.

CAAS Capital Management first reported a position in TMCI in Q2 2021 and held it in 1 quarter. The position peaked at $4.69M in Q2 2021. 62 funds tracked by Wall St. Rank hold TMCI as of Q3 2021.

  • CAAS Capital Management reported no remaining Treace Medical Concepts position as of Q3 2021 after selling out during the quarter.
  • CAAS Capital Management sold 150,000 Treace Medical Concepts shares in Q3 2021, an estimated $4.69M.
  • CAAS Capital Management first reported a position in Treace Medical Concepts in Q2 2021 and held it in 1 quarter.
  • CAAS Capital Management's Treace Medical Concepts position peaked at $4.69M in Q2 2021.
  • 62 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q3 2021.

Based on CAAS Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.